Frontmatter

Articles in the same Issue

1. Frontmatter
2. Review
3. Review of pharmacogenetics studies of L-asparaginase hypersensitivity in acute lymphoblastic leukemia points to variants in the GRIA1 gene
4. Population Pharmacogenomics
5. Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population
6. Original Articles
7. Role of treatment-modifying MTHFR677C>T and 1298A>C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy
8. Genotyping CYP2D6 by three different methods: advantages and disadvantages
9. Relationship between metabolic phenotypes and genotypes of CYP1A2 and CYP2A6 in the Nigerian population
10. Influence of genetic polymorphisms of CYP3A5 and ABCB1 on sirolimus pharmacokinetics, patient and graft survival and other clinical outcomes in renal transplant
11. Cytotoxicity and cytochrome P450 inhibitory activities of Clinacanthus nutans
12. Verification of propofol sulfate as a further human propofol metabolite using LC-ESI-QQQ-MS and LC-ESI-QTOF-MS analysis